151 related articles for article (PubMed ID: 25266013)
1. Molecular epidemiology of and genetic susceptibility to esophageal cancer.
Bajpai M; Das KM; Lefferts J; Lisovsky M; Mashimo H; Phillips WA; Srivastava A; To H
Ann N Y Acad Sci; 2014 Sep; 1325():40-8. PubMed ID: 25266013
[TBL] [Abstract][Full Text] [Related]
2. Translational research on Barrett's esophagus.
Baruah A; Buttar N; Chandra R; Chen X; Clemons NJ; Compare D; El-Rifai W; Gu J; Houchen CW; Koh SY; Li W; Nardone G; Phillips WA; Sharma A; Singh I; Upton MP; Vega KJ; Wu X
Ann N Y Acad Sci; 2014 Sep; 1325():170-86. PubMed ID: 25266024
[TBL] [Abstract][Full Text] [Related]
3. Strategy for prevention of cancers of the esophagus.
Akiyama J; Alexandre L; Baruah A; Buttar N; Chandra R; Clark AB; Hart AR; Hawk E; Kandioler D; Kappel S; Krishnadath SK; Sharma A; Singh I; Straub D; Triadafilopoulos G; Umar A; Wolf B
Ann N Y Acad Sci; 2014 Sep; 1325():108-26. PubMed ID: 25266020
[TBL] [Abstract][Full Text] [Related]
4. Superficial and early cancers of the esophagus.
Davydov М; Delektorskaya VV; Kuvshinov YP; Lisovsky M; Pirogov SS; Udagawa H; Ueno M; Wang G
Ann N Y Acad Sci; 2014 Sep; 1325():159-69. PubMed ID: 25266023
[TBL] [Abstract][Full Text] [Related]
5. Progression of esophageal dysplasia to cancer.
Appelman HD; Matejcic M; Parker MI; Riddell RH; Salemme M; Swanson PE; Villanacci V
Ann N Y Acad Sci; 2014 Sep; 1325():96-107. PubMed ID: 25266019
[TBL] [Abstract][Full Text] [Related]
6. Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies.
Palles C; Findlay JM; Tomlinson I
Adv Exp Med Biol; 2016; 908():265-90. PubMed ID: 27573776
[TBL] [Abstract][Full Text] [Related]
7. Benign and precursor lesions in the esophagus.
Akiyama J; Bertelé A; Brock C; Hvid-Jensen F; Ichiya T; Krarup AL; Majewski M; Rubio CA; Sarosiek J; Scarpignato C; Schmidt PT; Teich S; Triadafilopoulos G; Wallner G
Ann N Y Acad Sci; 2014 Sep; 1325():226-41. PubMed ID: 25266028
[TBL] [Abstract][Full Text] [Related]
8. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
11. Studying Cancer Evolution in Barrett's Esophagus and Esophageal Adenocarcinoma.
Paulson TG
Adv Exp Med Biol; 2016; 908():213-36. PubMed ID: 27573774
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
13. Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma.
Ochs-Balcom HM; Falk G; Grady WM; Kinnard M; Willis J; Elston R; Eng C; Chak A
Transl Res; 2007 Jul; 150(1):3-17. PubMed ID: 17585859
[TBL] [Abstract][Full Text] [Related]
14. Diet and esophageal disease.
Dawsey SM; Fagundes RB; Jacobson BC; Kresty LA; Mallery SR; Paski S; van den Brandt PA
Ann N Y Acad Sci; 2014 Sep; 1325():127-37. PubMed ID: 25266021
[TBL] [Abstract][Full Text] [Related]
15. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma.
Kalatskaya I
Ann N Y Acad Sci; 2016 Oct; 1381(1):74-91. PubMed ID: 27415609
[TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus: cancer and molecular biology.
Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic analysis of esophageal cancers.
Caygill CP; Gatenby PA; Herceg Z; Lima SC; Pinto LF; Watson A; Wu MS
Ann N Y Acad Sci; 2014 Sep; 1325():69-76. PubMed ID: 25266016
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
Levine DM; Ek WE; Zhang R; Liu X; Onstad L; Sather C; Lao-Sirieix P; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Murray LJ; Reid BJ; Chow WH; Risch HA; Nyrén O; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Chanock SJ; Harrington P; Caldas I; Debiram-Beecham I; Caldas C; Hayward NK; Pharoah PD; Fitzgerald RC; Macgregor S; Whiteman DC; Vaughan TL
Nat Genet; 2013 Dec; 45(12):1487-93. PubMed ID: 24121790
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
20. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
